Jeff Ajer
Directeur/Bestuurslid bij NEKTAR THERAPEUTICS
Vermogen: 6 M $ op 30-04-2024
Actieve functies van Jeff Ajer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NEKTAR THERAPEUTICS | Directeur/Bestuurslid | 21-09-2017 | - |
| Independent Dir/Board Member | 21-09-2017 | - |
Loopbaan van Jeff Ajer
Eerdere bekende functies van Jeff Ajer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-09-2005 | 20-05-2024 |
| Verkoop & Marketing | 01-09-2005 | - | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-11-2003 | 01-08-2005 |
| SangStat Medical Corp. | Verkoop & Marketing | - | 01-01-2003 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01-06-1986 | 01-07-1999 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-08-2005 | - |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | 01-02-2017 | - |
| Independent Dir/Board Member | 01-02-2017 | - |
Opleiding van Jeff Ajer
| University of California, Irvine | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 2 |
| Director/Board Member | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| SangStat Medical Corp. | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
